US Congressman spotlights differential pricing of BI’s diabetes drug in US, India

US Congressman Ro Khanna criticizes multinational Boehringer Ingelheim for selling diabetes drug at significantly higher prices in the US compared …

Share on Facebook

Tweet

Follow us

Save